Antitrust trials against Google, a court ruling on Meta’s use of teen data and Pegasystems’ Nov. 15 appeal argument to reduce Appan’s $2 billion jury award are key November catalysts to watch. This Bloomberg Intelligence litigation and policy outlook episode, hosted by financials litigation analyst Elliott Stein, gathered the team to discuss these and other catalysts. the trial ends in the DOJ’s suit challenging the JetBlue-Spirit M&A, and Berkshire Hathaway’s energy subsidiary PacifiCorp will be in court Nov. 9 to trim its exposure in the Oregon wildfire litigation. Virtu likely files its motion by Nov. 13 to dismiss an SEC lawsuit accusing the company of failing to enforce information barriers around trade data. We await court rulings in Bayer Roundup and Peloton securities fraud litigation. We also discussed a Federal Reserve proposal to lower debit-card fees, the Basel III endgame proposal to increase bank-capital requirements and what Mike Johnson’s ascension to the House Speaker role means for a potential government shutdown this year. In health care, we looked at an FDA proposal to extend medical-device oversight to laboratory-developed tests and a proposal to exempt orphan drugs that treat more than one disease from the drug pricing provisions of the Inflation Reduction Act.

See omnystudio.com/listener for privacy information.